LUND, S.E., September 19, 2024—TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), proudly announces the launch of its new mission statement and tagline: Empowering Partners. Enriching Lives. This…
TFS HealthScience partners with RetinAI and MAXO to advance clinical studies in dry eye disease with AI-driven data management and innovative solutions.
TFS appoints Kris O’Brien as VP, Head of Oncology & Rare Diseases, enhancing leadership in clinical trials for complex therapies.
Leading CRO, TFS HealthScience appoints Victoria Hornagold as VP of Clinical Development Services, enhancing client delivery with a patient-centric focus.
TFS HealthScience achieves top 15% ranking with a Silver Rating from EcoVadis, underscoring our dedication to sustainability and responsible business practices.
TFS HealthScience announces the release of its Sustainability Report 2023, showcasing significant strides in environmental stewardship, social responsibility, and sustainable business practices.
